Updates are available Erratum dated 2015-09-16
Click to view Erratum: https://doi.org/10.1038/nature15704
-
Authors
Jaunmuktane, Zane
Mead, Simon
Ellis, Matthew
Wadsworth, Jonathan D. F.
Nicoll, Andrew J.
Kenny, Joanna
Launchbury, Francesca
Linehan, Jacqueline
Richard-Loendt, Angela
Walker, A. Sarah
Rudge, Peter
Collinge, John
Brandner, Sebastian
- License Information
-
More Information
Article History
Received: 26 April 2015
Accepted: 14 August 2015
First Online: 9 September 2015
Change Date: 11 September 2015
Change Type: Update
Change Details: Due to an administrative error, an incorrect version of the Competing Financial Interests (CFI) statement was published in relation to this paper. Although the published CFI statement did reference the authors' affiliation with D-Gen, it did not contain all of the information provided to <i>Nature</i> by the authors about the interests of the company. As soon as <i>Nature</i> was made aware of the error, we acted quickly to correct the text and expand the CFI statement. The CFI statement for this paper as originally published was "J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, which supplies antibody ICSM35." The updated CFI statement is “J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen supplied antibody ICSM35”.
Competing interests
: J.C. is a Director and J.C. and J.D.F.W. are shareholders of D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, decontamination and therapeutics. D-Gen supplied antibody ICSM35.
